论文部分内容阅读
目的观察血塞通软胶囊联合奥扎格雷钠治疗急性脑梗死的临床疗效。方法急性脑梗死患者112例,随机分为观察组和对照组。其中观察组57例,对照组55例。两组患者均给予常规治疗,在此基础上观察组给予血塞通软胶囊120mg口服2次/d,同时给予奥扎格雷钠80mg加入250ml生理盐水中静脉滴注,2次/d,共应用14d。对照组在常规治疗基础上给予奥扎格雷钠80mg加入250ml生理盐水中静脉滴注,2次/d,共应用14d。结果观察组总有效率高于对照组,差异有统计学意义(P<0.05)。结论血塞通软胶囊联合奥扎格雷钠治疗急性脑梗死临床疗效显著,具有临床价值。
Objective To observe the clinical effect of Xuesaitong soft capsule combined with ozagrel sodium on acute cerebral infarction. Methods 112 patients with acute cerebral infarction were randomly divided into observation group and control group. 57 cases in the observation group and 55 cases in the control group. Two groups of patients were given conventional treatment, on the basis of observation group given Xuesaitong soft capsule 120mg orally 2 times / d, at the same time give Ozagrel sodium 80mg added 250ml saline intravenous infusion, 2 times / d, were used 14d. The control group was given Ozagrel sodium 80mg intravenously on the basis of routine treatment with 250ml normal saline for 2 times daily for 14 days. Results The total effective rate in the observation group was higher than that in the control group, with significant difference (P <0.05). Conclusion Xuesaitong soft capsules combined with ozagrel sodium in the treatment of acute cerebral infarction clinical efficacy is significant, with clinical value.